181-195 of 284
Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
Heart MattersAddressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
Michelle Kittleson, MD, PhD
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Heart MattersOvercoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Michelle Kittleson, MD, PhD
Understanding the Pathophysiology Behind ATTR-CM
Heart MattersUnderstanding the Pathophysiology Behind ATTR-CM
Frederick Ruberg, MD
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Project Oncology®Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
ATTR-CM Screening: How Economic Factors Can Impact Care
Heart MattersATTR-CM Screening: How Economic Factors Can Impact Care
Kibum Kim, PhD
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiersDiagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Nancy Kuntz, MD
- advertisement
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiersDuchenne Muscular Dystrophy Management: Analyzing Current Approaches
Nancy Kuntz, MD
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Project Oncology®Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Shaji K. Kumar, MD
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiersGeneralized Myasthenia Gravis Management: Evaluating Long-Term Effects
Maxwell H. Levy, MD
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Project Oncology®The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Urvi A. Shah, MD, MS
Patient Case: ATTRwt-CM Discovered Decades After Heart Transplant
Heart MattersPatient Case: ATTRwt-CM Discovered Decades After Heart Transplant
Lily Stern, MD
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Project Oncology®Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
- advertisement
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
NeuroFrontiersDevelopments in Duchenne Muscular Dystrophy Care: Examining the Options
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
NeuroFrontiersDifferentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Maxwell H. Levy, MD
Silent Brain Damage in ATTR-CM: Exploring Neurological Impacts
Spotlight On ATTR-CMSilent Brain Damage in ATTR-CM: Exploring Neurological Impacts
